Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer.

Watt GP, Reiner AS, Smith SA, Stram DO, Capanu M, Malone KE, Lynch CF, John EM, Knight JA, Mellemkjær L, Bernstein L, Brooks JD, Woods M, Liang X, Haile RW, Riaz N, Conti DV, Robson M, Duggan D, Boice JD Jr, Shore RE, Tischkowitz M, Orlow I, Thomas DC, Concannon P, Bernstein JL.

JAMA Netw Open. 2019 Sep 4;2(9):e1912259. doi: 10.1001/jamanetworkopen.2019.12259.

2.

Preventive drug therapy and contralateral breast cancer: summary of the evidence of clinical trials and observational studies.

Bens A, Langballe R, Bernstein JL, Cronin-Fenton D, Friis S, Mellemkjaer L.

Acta Oncol. 2019 Nov;58(11):1581-1593. doi: 10.1080/0284186X.2019.1643915. Epub 2019 Aug 8.

PMID:
31393200
3.

Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study.

Gottschau M, Jensen A, Reinholdt K, Guleria S, Munk C, Mellemkjær L, Kjær SK.

Breast Cancer Res Treat. 2019 Nov;178(1):199-205. doi: 10.1007/s10549-019-05369-8. Epub 2019 Jul 30.

PMID:
31364000
4.

CYP2D6 phenotype, tamoxifen, and risk of contralateral breast cancer in the WECARE Study.

Brooks JD, Comen EA, Reiner AS, Orlow I, Leong SF, Liang X, Mellemkjær L, Knight JA, Lynch CF, John EM, Bernstein L, Woods M, Doody DR; WECARE Study collaborative group, Malone KE, Bernstein JL.

Breast Cancer Res. 2018 Dec 10;20(1):149. doi: 10.1186/s13058-018-1083-y.

5.

Nonaspirin NSAIDs and contralateral breast cancer risk.

Bens A, Cronin-Fenton D, Dehlendorff C, Jensen MB, Ejlertsen B, Kroman N, Friis S, Mellemkjaer L.

Int J Cancer. 2019 Mar 15;144(6):1243-1250. doi: 10.1002/ijc.31949. Epub 2018 Dec 6.

PMID:
30362513
6.

Statin use and risk of contralateral breast cancer: a nationwide cohort study.

Langballe R, Cronin-Fenton D, Dehlendorff C, Jensen MB, Ejlertsen B, Andersson M, Friis S, Mellemkjær L.

Br J Cancer. 2018 Nov;119(10):1297-1305. doi: 10.1038/s41416-018-0252-1. Epub 2018 Oct 24.

7.

Low-dose aspirin use and risk of contralateral breast cancer: a Danish nationwide cohort study.

Bens A, Friis S, Dehlendorff C, Jensen MB, Ejlertsen B, Kroman N, Cronin-Fenton D, Mellemkjær L.

Prev Med. 2018 Nov;116:186-193. doi: 10.1016/j.ypmed.2018.09.015. Epub 2018 Sep 24.

PMID:
30261243
8.

Mortality after contralateral breast cancer in Denmark.

Langballe R, Frederiksen K, Jensen MB, Andersson M, Cronin-Fenton D, Ejlertsen B, Mellemkjær L.

Breast Cancer Res Treat. 2018 Sep;171(2):489-499. doi: 10.1007/s10549-018-4846-3. Epub 2018 Jun 11.

PMID:
29948403
9.

Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study.

Reiner AS, Sisti J, John EM, Lynch CF, Brooks JD, Mellemkjær L, Boice JD, Knight JA, Concannon P, Capanu M, Tischkowitz M, Robson M, Liang X, Woods M, Conti DV, Duggan D, Shore R, Stram DO, Thomas DC, Malone KE, Bernstein L; WECARE Study Collaborative Group, Bernstein JL.

J Clin Oncol. 2018 May 20;36(15):1513-1520. doi: 10.1200/JCO.2017.77.3424. Epub 2018 Apr 5.

10.

Worse survival after breast cancer in women with anorexia nervosa.

Bens A, Papadopoulos FC, Pukkala E, Ekbom A, Gissler M, Mellemkjær L.

Breast Cancer Res Treat. 2018 Apr;168(2):495-500. doi: 10.1007/s10549-017-4618-5. Epub 2017 Dec 12.

PMID:
29235044
11.

Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study.

Dreyer L, Cordtz RL, Hansen IMJ, Kristensen LE, Hetland ML, Mellemkjaer L.

Ann Rheum Dis. 2018 Apr;77(4):510-514. doi: 10.1136/annrheumdis-2017-212086. Epub 2017 Dec 7.

PMID:
29217620
12.

Agreement between self-reported and register-based cardiovascular events among Danish breast cancer survivors.

Langballe R, John EM, Malone KE, Bernstein L, Knight JA, Lynch CF, Howell RM, Shore R, Woods M, Concannon P; WECARE Study Collaborative Group, Bernstein JL, Mellemkjær L.

J Cancer Surviv. 2018 Feb;12(1):95-100. doi: 10.1007/s11764-017-0648-6. Epub 2017 Sep 29.

13.

Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.

Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L, Tischkowitz M, Haile RW, Shen R, Malone KE, Woods M, Liang X, Morrow M, Bernstein JL; WECARE Study Collaborative Group.

Breast Cancer Res. 2017 Jul 19;19(1):83. doi: 10.1186/s13058-017-0874-x.

14.

Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.

Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF, Woods M, Liang X, Haile RW, Duggan DJ, Shore RE, Smith SA, Thomas DC, Stram DO, Bernstein JL; WECARE Study Collaborative Group.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx051.

15.

Risk of skin cancer following tamoxifen treatment in more than 16,000 breast cancer patients: a cohort study.

Praestegaard C, Kjaer SK, Andersson M, Steding-Jensen M, Frederiksen K, Mellemkjaer L.

Breast Cancer. 2016 Nov;23(6):908-916. Epub 2015 Dec 11.

PMID:
26660140
16.

Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.

Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE, Stovall M; WECARE Study Collaborative Group, Bernstein JL.

Cancer Med. 2016 Nov;5(11):3282-3291. doi: 10.1002/cam4.890. Epub 2016 Oct 3.

17.

Ovarian and tubal cancer in Denmark: an update on incidence and survival.

Gottschau M, Mellemkjaer L, Hannibal CG, Kjaer SK.

Acta Obstet Gynecol Scand. 2016 Oct;95(10):1181-9. doi: 10.1111/aogs.12948. Epub 2016 Aug 20.

PMID:
27454324
18.

Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study.

Mogensen JB, Kjær SK, Mellemkjær L, Jensen A.

Gynecol Oncol. 2016 Oct;143(1):87-92. doi: 10.1016/j.ygyno.2016.07.095. Epub 2016 Jul 16.

PMID:
27430396
19.

Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.

Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS, Liang X, Woods M, Concannon PJ; WECARE Study Collaborative Group, Bernstein JL.

Breast Cancer Res. 2016 Jul 12;18(1):65. doi: 10.1186/s13058-016-0726-0.

20.

Mortality Among Women With Cervical Cancer During or Shortly After a Pregnancy in Denmark 1968 to 2006.

Eibye S, Krüger Kjær S, Nielsen TS, Mellemkjær L.

Int J Gynecol Cancer. 2016 Jun;26(5):951-8. doi: 10.1097/IGC.0000000000000708.

PMID:
27101585
21.

Risk of virus-associated cancer in female arthritis patients treated with biological DMARDs-a cohort study.

Cordtz R, Mellemkjær L, Glintborg B, Hetland ML, Madsen OR, Jensen Hansen IM, Dreyer L.

Rheumatology (Oxford). 2016 Jun;55(6):1017-22. doi: 10.1093/rheumatology/kew012. Epub 2016 Feb 24.

PMID:
26912584
22.

Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.

Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M, Liang X, John EM; WECARE Study Collaborative Group.

Springerplus. 2015 Dec 30;4:825. doi: 10.1186/s40064-015-1642-y. eCollection 2015.

23.

Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS).

Holmqvist AS, Olsen JH, Mellemkjaer L, Garwicz S, Hjorth L, Moëll C, Månsson B, Tryggvadottir L, Hasle H, Winther JF; ALiCCS study group.

Ann Rheum Dis. 2016 Sep;75(9):1622-9. doi: 10.1136/annrheumdis-2015-207659. Epub 2015 Nov 10.

PMID:
26555403
24.

Cancer Incidence among Patients with Anorexia Nervosa from Sweden, Denmark and Finland.

Mellemkjaer L, Papadopoulos FC, Pukkala E, Ekbom A, Gissler M, Christensen J, Olsen JH.

PLoS One. 2015 May 22;10(5):e0128018. doi: 10.1371/journal.pone.0128018. eCollection 2015.

25.

Joint occurrence of Merkel cell carcinoma and non-Hodgkin lymphomas in four Nordic countries.

Koljonen V, Rantanen M, Sahi H, Mellemkjær L, Hansen BT, Chen T, Hemminki K, Pukkala E.

Leuk Lymphoma. 2015;56(12):3315-9. doi: 10.3109/10428194.2015.1040010. Epub 2015 May 26.

PMID:
25899400
26.

Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis.

Cordtz R, Mellemkjær L, Glintborg B, Hetland ML, Dreyer L.

Ann Rheum Dis. 2015 Jul;74(7):1479-80. doi: 10.1136/annrheumdis-2014-206909. Epub 2015 Mar 5. No abstract available.

PMID:
25744102
27.

Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.

Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L.

Gynecol Oncol. 2015 Jan;136(1):99-103. doi: 10.1016/j.ygyno.2014.11.012. Epub 2014 Nov 20.

PMID:
25451694
28.

Incidence of metachronous contralateral breast cancer in Denmark 1978-2009.

Rasmussen CB, Kjær SK, Ejlertsen B, Andersson M, Jensen MB, Christensen J, Langballe R, Mellemkjær L.

Int J Epidemiol. 2014 Dec;43(6):1855-64. doi: 10.1093/ije/dyu202. Epub 2014 Oct 16.

PMID:
25326461
29.

Risk of contralateral breast cancer after tamoxifen use among Danish women.

Mellemkjær L, Steding-Jessen M, Frederiksen K, Andersson M, Ejlertsen B, Jensen MB, Olsen JH.

Ann Epidemiol. 2014 Nov;24(11):843-8. doi: 10.1016/j.annepidem.2014.08.003. Epub 2014 Sep 6.

PMID:
25277504
30.

Prolonged risk of specific malignancies following cyclophosphamide therapy among patients with granulomatosis with polyangiitis.

Faurschou M, Mellemkjaer L, Voss A, Keller KK, Hansen IT, Baslund B.

Rheumatology (Oxford). 2015 Aug;54(8):1345-50. doi: 10.1093/rheumatology/keu372. Epub 2014 Sep 17.

PMID:
25234661
31.

Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009.

Rugbjerg K, Mellemkjaer L, Boice JD, Køber L, Ewertz M, Olsen JH.

J Natl Cancer Inst. 2014 May 21;106(6):dju110. doi: 10.1093/jnci/dju110. Print 2014 Jun.

PMID:
24848622
32.

Incidence of pregnancy-associated cancer in Denmark, 1977-2006.

Eibye S, Kjær SK, Mellemkjær L.

Obstet Gynecol. 2013 Sep;122(3):608-17. doi: 10.1097/AOG.0b013e3182a057a2.

PMID:
23921869
33.

Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study.

Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ, Schiermeyer K; WECARE Study Collaborative Group, Bernstein JL, Figueiredo JC.

Cancer Causes Control. 2013 Aug;24(8):1605-14. doi: 10.1007/s10552-013-0237-6. Epub 2013 Jun 18.

34.

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group.

Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.

35.

Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.

Brooks JD, Teraoka SN, Malone KE, Haile RW, Bernstein L, Lynch CF, Mellemkjær L, Duggan DJ, Reiner AS, Concannon P, Schiermeyer K, Lewinger JP; WECARE Study Collaborative Group, Bernstein JL, Figueiredo JC.

Int J Mol Epidemiol Genet. 2013;4(1):35-48. Epub 2013 Mar 18.

36.

Second primary cancers after adjuvant radiotherapy in early breast cancer patients: a national population based study under the Danish Breast Cancer Cooperative Group (DBCG).

Grantzau T, Mellemkjær L, Overgaard J.

Radiother Oncol. 2013 Jan;106(1):42-9. doi: 10.1016/j.radonc.2013.01.002. Epub 2013 Feb 8.

37.

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.

Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL.

J Clin Oncol. 2013 Feb 1;31(4):433-9. doi: 10.1200/JCO.2012.43.2013. Epub 2012 Dec 26.

38.

Variation in genes related to obesity, weight, and weight change and risk of contralateral breast cancer in the WECARE Study population.

Brooks JD, Bernstein L, Teraoka SN, Knight JA, Mellemkjær L, John EM, Malone KE, Reiner AS, Lynch CF, Concannon P, Haile RW, Bernstein JL; WECARE Study Collaborative Group.

Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2261-7. doi: 10.1158/1055-9965.EPI-12-1036. Epub 2012 Oct 2.

39.

Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry.

Dreyer L, Mellemkjær L, Andersen AR, Bennett P, Poulsen UE, Juulsgaard Ellingsen T, Hansen TH, Jensen DV, Linde L, Lindegaard HM, Loft AG, Nordin H, Omerovic E, Rasmussen C, Schlemmer A, Tarp U, Hetland ML.

Ann Rheum Dis. 2013 Jan;72(1):79-82. doi: 10.1136/annrheumdis-2012-201969. Epub 2012 Sep 3.

40.

Leg length, sitting height and postmenopausal breast cancer risk.

Mellemkjær L, Christensen J, Frederiksen K, Baker JL, Olsen A, Sørensen TI, Tjønneland A.

Br J Cancer. 2012 Jun 26;107(1):165-8. doi: 10.1038/bjc.2012.244. Epub 2012 Jun 7.

41.

Second primary malignancies among women with uterine sarcoma.

Koivisto-Korander R, Scélo G, Ferro G, Mellemkjaer L, Hemminki K, Weiderpass E, Tamaro S, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Brennan P, Straif K, Pukkala E.

Gynecol Oncol. 2012 Jul;126(1):30-5. doi: 10.1016/j.ygyno.2012.04.002. Epub 2012 Apr 6.

PMID:
22487538
42.

Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study.

Brooks JD, Boice JD Jr, Stovall M, Reiner AS, Bernstein L, John EM, Lynch CF, Mellemkjær L, Knight JA, Thomas DC, Haile RW, Smith SA, Capanu M, Bernstein JL, Shore RE; WECARE Collaborative Group.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):917-24. doi: 10.1016/j.ijrobp.2012.01.047. Epub 2012 Apr 6.

43.

Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer, and Radiation Epidemiology (WECARE) Study.

Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X, Smith SA, Mychaleckyj J, Hou X, Mellemkjaer L, Boice JD Jr, Siniard A, Duggan D, Thomas DC; WECARE Study Collaborative Group, Concannon P.

Breast Cancer Res. 2011;13(6):R114. doi: 10.1186/bcr3057. Epub 2011 Nov 17.

44.

Incidence and outcome of male breast cancer: an international population-based study.

Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Larønningen S, Mellemkjær L, Czene K, Hartman M.

J Clin Oncol. 2011 Nov 20;29(33):4381-6. doi: 10.1200/JCO.2011.36.8902. Epub 2011 Oct 3.

PMID:
21969512
45.

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study.

Brooks JD, Teraoka SN, Reiner AS, Satagopan JM, Bernstein L, Thomas DC, Capanu M, Stovall M, Smith SA, Wei S, Shore RE, Boice JD Jr, Lynch CF, Mellemkjaer L, Malone KE, Liang X; Wecare Study Collaborative Group, Haile RW, Concannon P, Bernstein JL.

Hum Mutat. 2012 Jan;33(1):158-64. doi: 10.1002/humu.21604. Epub 2011 Sep 29.

46.

Body mass index and risk of second primary breast cancer: the WECARE Study.

Brooks JD, John EM, Mellemkjær L, Reiner AS, Malone KE, Lynch CF, Figueiredo JC, Haile RW, Shore RE; WECARE Study Collaborative Group, Bernstein JL, Bernstein L.

Breast Cancer Res Treat. 2012 Jan;131(2):571-80. doi: 10.1007/s10549-011-1743-4. Epub 2011 Sep 3.

47.

High risk of ischemic heart disease in patients with lupus nephritis.

Faurschou M, Mellemkjaer L, Starklint H, Kamper AL, Tarp U, Voss A, Jacobsen S.

J Rheumatol. 2011 Nov;38(11):2400-5. doi: 10.3899/jrheum.110329. Epub 2011 Sep 1.

PMID:
21885497
48.

Risk of primary non-breast cancer after female breast cancer by age at diagnosis.

Mellemkjær L, Christensen J, Frederiksen K, Pukkala E, Weiderpass E, Bray F, Friis S, Andersson M, Olsen JH.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1784-92. doi: 10.1158/1055-9965.EPI-11-0009. Epub 2011 Jun 8.

49.

Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapy.

Langballe R, Olsen JH, Andersson M, Mellemkjær L.

Eur J Cancer. 2011 Apr;47(6):946-52. doi: 10.1016/j.ejca.2011.01.004. Epub 2011 Feb 19.

PMID:
21339063
50.

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

Malone KE, Begg CB, Haile RW, Borg A, Concannon P, Tellhed L, Xue S, Teraoka S, Bernstein L, Capanu M, Reiner AS, Riedel ER, Thomas DC, Mellemkjaer L, Lynch CF, Boice JD Jr, Anton-Culver H, Bernstein JL.

J Clin Oncol. 2010 May 10;28(14):2404-10. doi: 10.1200/JCO.2009.24.2495. Epub 2010 Apr 5.

Supplemental Content

Loading ...
Support Center